• Cardiogreen (Indocyanine Green): Uses & Limits

  2026-09-11

  Cardiogreen, also called Indocyanine green, is a near-infrared tricarbocyanine dye that remains primarily within the vascular space after intravenous administration. Its documented uses include cardiac output measurement, liver blood flow assessment, ophthalmic angiography, and experimental apoptosis induction in photodynamic therapy.

• 5-(N,N-dimethyl)-Amiloride: Assay Design

  2026-09-11

  5-(N,N-dimethyl)-Amiloride hydrochloride is a precise tool for dissecting sodium–proton exchange, intracellular pH regulation, and endothelial injury. This guide develops a causal assay framework that connects ion-transport perturbation with moesin, barrier, and cardiac readouts without overstating the available evidence.

• Influenza Hemagglutinin (HA) Peptide for Reliable IP

  2026-09-10

  Learn how Influenza Hemagglutinin (HA) Peptide, SKU A6004, supports controlled HA-tagged protein detection, immunoprecipitation, and elution when cell viability or cytotoxicity data require mechanistic follow-up. This scenario-based guide connects product specifications with practical assay design, interpretation, and vendor-selection decisions.

• 2',7'-Dichlorofluorescein diacetate in Pancreatic Cancer

  2026-09-10

  A translational guide to using 2',7'-Dichlorofluorescein diacetate for intracellular ROS measurement, interpreting redox-responsive nanocarrier studies, and connecting fluorescence signals with tumor penetration, extracellular matrix remodeling, mitochondrial function, and therapeutic decision-making.

• Nicotinamide Riboside Chloride in RGC Translation

  2026-09-09

  Nicotinamide Riboside Chloride (NIAGEN) offers a mechanistically grounded way to examine NAD+ availability alongside reproducible iPSC-derived retinal ganglion cell models. This thought-leadership perspective connects NAD+ biology with dual SMAD and Wnt-controlled differentiation, while separating established evidence from testable translational hypotheses in glaucoma and neurodegenerative disease research.

• ARCA and the Translational Logic of mRNA Therapy

  2026-09-09

  Synthetic mRNA performance is shaped by more than delivery: cap orientation influences translation initiation, RNA persistence, and the amount of therapeutic protein produced per particle. This thought-leadership analysis connects ARCA chemistry with the preclinical stroke study by Gao et al., showing how translational researchers can evaluate capping as a strategic variable without overstating evidence.

• Estradiol Workflows for ER Signaling Research

  2026-09-09

  Build reproducible Estradiol assays that separate ERα, ERβ, autophagy, and downstream transcriptional effects. This practical guide translates new multi-organ evidence into dose planning, controls, readouts, and troubleshooting strategies for cell and translational research.

• Rocilinostat (ACY-1215) HDAC6 Research Workflow

  2026-09-08

  Rocilinostat (ACY-1215) provides a selective way to connect HDAC6 engagement with α-tubulin acetylation, multiple myeloma phenotypes, and proteasome-inhibitor combination responses. This workflow also shows how to examine cilia-related observations without confusing HDAC6 pharmacology with the SMPD4–ceramide mechanism.

• ARL4C, FLS Proliferation, and RA Progression

  2026-09-07

  This study integrates single-cell and bulk RNA sequencing with cellular perturbation, macrophage co-culture, and collagen-induced arthritis modeling to identify ARL4C as a driver of aggressive fibroblast-like synoviocyte behavior in rheumatoid arthritis. Its findings connect ARL4C-dependent synoviocyte proliferation and invasion with macrophage polarization and joint damage, while also defining important boundaries for translational interpretation.

• RG108 DNA Methyltransferase Inhibitor Workflow

  2026-09-07

  RG108 is a non-covalent DNA methyltransferase inhibitor for testing how altered methylation affects gene expression, especially in leukemia and other cancer research models. This workflow combines controlled dosing, locus-focused validation, and troubleshooting strategies to distinguish genuine epigenetic reprogramming from solvent toxicity or nonspecific growth inhibition.

• Caspase-3 Fluorometric Assay Kit Workflow

  2026-09-05

  The Caspase-3 Fluorometric Assay Kit converts DEVD-dependent protease activity into a quantitative AFC fluorescence signal for rapid apoptosis research. Its most useful application is distinguishing caspase-driven apoptosis from ferroptosis-associated stress in RSL3-treated cancer models while supporting orthogonal PARP1 and cell-death analyses.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-09-04

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation and aldosterone signaling. It is not a general-purpose peptide reagent and should not be extended to unrelated signaling assays without independent validation.

• Imipenem Workflow for Antibacterial Research

  2026-09-04

  Imipenem supports more than endpoint susceptibility testing: its PBP-directed activity enables time-resolved bacterial killing, resistance profiling, and carefully controlled immune-cell assays. This workflow connects practical solution handling with translational sepsis animal model design while keeping evidence-backed findings separate from exploratory recommendations.

• IDH1-R132H Autopalmitoylation in Cancer

  2026-09-03

  The reference study identifies C269 autopalmitoylation as a mutation-associated regulatory mechanism that enhances IDH1-R132H activity, dimerization, and oncometabolite production. Its chemoproteomic and functional data connect fatty-acid availability with IDH1-mutant metabolic and epigenetic phenotypes, while also highlighting a hydrophobic pocket with therapeutic relevance.

• Hydroxychloroquine Sulfate Workflow Guide

  2026-09-03

  Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous research reagent for investigating autophagy pathway modulation and TLR7/9-associated responses in autoimmune disease research. It is suited to short-term, water-based workflows, but should not be selected for DMSO- or ethanol-based stocks or long-term storage of prepared solutions.

8629 records 1/576 page Next 12345 下5页 Last page